Pacliaqualip 30Mg Inj Substitute
Alkem Laboratories Ltd
₹1131
(₹226.2/ 1ml)
Zydus Healthcare Ltd
₹1131
(₹226.2/ 1ml)
Esperer Bio Research Pvt Ltd
₹1140
(₹228.0/ 1ml)
Fresenius Kabi India Pvt Ltd
₹1150.5
(₹230.1/ 1ml)
Intas Pharmaceuticals Ltd
₹1150.5
(₹230.1/ 1ml)
Dr Reddy's Laboratories Ltd
₹1150.5
(₹230.1/ 1ml)
Delarc Pharmaceuticals Pvt Ltd
₹1206
(₹241.2/ 1ml)
Admac Pharma Ltd
₹1206
(₹241.2/ 1ml)
Getwell Oncology Pvt Ltd
₹1206
(₹241.2/ 1ml)
RPG Life Sciences Ltd
₹1230.9
(₹246.18/ 1ml)
Emcure Pharmaceuticals Ltd
₹1278.5
(₹255.7/ 1ml)
GLS Pharma Ltd
₹1575
(₹315.0/ 1ml)
Khandelwal Laboratories Pvt Ltd
₹481.8
(₹481.8/ 1ml)
Bhardwaj India Pvt Ltd
₹1050
(₹1050.0 per unit)
Fresenius Kabi Oncology Ltd
₹4524
(₹4524.0 per unit)

Patients may explore substitutes in the following scenarios:
Before you switch from Pacliaqualip 30Mg Inj to another medicine, here are some important points to keep in mind:
Most substitutes contain the same active ingredient - PACLITAXEL-30MG, but the fillers, coating, or manufacturing quality may vary slightly.
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Pacliaqualip 30Mg Inj is used in the treatment of ovarian cancer, breast cancer, and non-small cell lung cancer. The detailed uses of Pacliaqualip 30Mg Inj are as follows:
Pacliaqualip 30Mg Inj belongs to the group of anti-cancer medicines called anti-microtubule agents used to treat various types of cancers, including ovarian and breast cancer (in advanced/spreading state or after surgery) and advanced-stage non-small cell lung cancer. It may also be used when other treatments have failed or in combination with other treatments. Pacliaqualip 30Mg Inj may also be indicated in patients with Kaposi’s sarcoma (cancer that develops from the cells that line lymph or blood vessels) associated with AIDS (Acquired Immuno-Deficiency Syndrome), where other treatments have not been effective. Pacliaqualip 30Mg Inj contains ‘Paclitaxel’, which works by preventing the growth of certain cancer cells.
RX
RX
RX